Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients

Annals of Oncology

Volumn 21, Issue 10, 2010, Pages 2017-2022

  Chua, T C ^a   Sarkar, A ^a   Saxena, A ^a   Glenn, D ^a   Zhao, J ^a   Morris, D L ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Lung metastases; Metastatic colorectal cancer; Pulmonary metastasectomy; Radiofrequency ablation; Renal cell carcinoma; Sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEST TUBE PLACEMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FLUOROSCOPY; GUIDED IMAGERY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOTHORAX; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; THORACOTOMY; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77957130812     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq098     Document Type: Article

References (24)

1. Kenneth RH, Gauri RV, Sarah HT et al. Metastatic patterns in adenocarcinoma. Cancer 2006; 106(7): 1624-1633.
2. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23): 2335-2342.
3. Flanigan RC, Salmon SE, Blumenstein BA et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345(23): 1655-1659.
4. Motzer RJ, Hutson TE, Tomczak P et al. Phase III randomized trial of sunitinib malate (SU11248) versus interferon-alfa (IFN-α) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC). J Clin Oncol 2006; 24(Suppl 18).
5. The International Registry of Lung Metastases, Writing Committee. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113(1): 37-49.
6. Timmerman RD, Bizekis CS, Pass HI et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59(3): 145-170.
7. Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 2008; 15(6): 1765-1774.
8. Zhu JC, Yan TD, Glenn D, Morris DL. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg 2009; 87: 1023-1029.
9. Pennathur A, Luketich JD, Abbas G et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007; 134(4): 857-864.
10. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984; 38(4): 323-330.
11. Tan KK, Lopes GdL Jr., Sim R. How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 2009; 13(4): 642-648.
12. Sano Y, Kanazawa S, Mimura H et al. A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery. J Thorac Oncol 2008; 3(3): 283-288.
13. Chen F, Fujinaga T, Sato K et al. Significance of tumor recurrence before pulmonary metastasis in pulmonary metastasectomy for soft tissue sarcoma. Eur J Surg Oncol 2009; 35(6): 660-665.
14. Watanabe K, Nagai K, Kobayashi A et al. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 2009; 96(9): 1058-1065.
15. Neuman HB, Patel A, Hanlon C et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 2007; 14(10): 2847-2853.
16. Murthy SC, Kim K, Rice TW et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 2005; 79(3): 996-1003.
17. Petersen RP, Hanish SI, Haney JC et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007; 133(1): 104-110.
18. Pogrebniak HW, Pass HI. Initial and reoperative pulmonary metastasectomy: indications, technique, and results. Semin Surg Oncol 1993; 9(2): 142-149.
19. Ketchedjian A, Daly BD, Fernando HC et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2006; 132(3): 544-548.
20. Pfannschmidt J, Klode J, Muley T et al. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 2006; 81(2): 448-454.
21. Ercan S, Nichols FCr, Trastek VF et al. Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma. Ann Thorac Surg 2004; 77(5): 1786-1791.
22. Internullo E, Cassivi SD, Van Raemdonck D et al. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol 2008; 3(11): 1257-1266.
23. Simon CJ, Dupuy DE, DiPetrillo TA et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243(1): 268-275.
24. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 2007; 62(7): 639-644.